Free Newsletter
DelBello draws added scrutiny for undisclosed funds
University of Cincinnati researcher Melissa DelBello is getting some added scrutiny after finding herself in Senator Charles Grassley's crosshairs. Grassley (R-IA) chastised the researcher for failing to disclose large sums of money she received from AstraZeneca a year after completing a study of Seroquel for bipolar disease. Grassley also criticized AstraZeneca's undisclosed financial ties to a company DelBello formed. DelBello will now be required to review all the money she has received from AstraZeneca in the last decade and will review all her financial ties to outside companies.
- check out the report in the Cincinnati Enquirer
Related Articles:
Seroquel researcher got cash from AZ. Fund report
Arms twisted, pharma promises disclosure. Disclosure report
Senate investigates pharma influence on CME. Senate report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: